Sheila Ulufatu

854 citations
15 papers · 451 indexed · h-index 10
Topics
Monoclonal and Polyclonal Antibodies Research (8 papers)HER2/EGFR in Cancer Research (5 papers)Glycosylation and Glycoproteins Research (2 papers)

In The Last Decade

Sheila Ulufatu

15 papers receiving 429 citations

Peers

Sheila Ulufatu
Comparison fields: 5 of 70
  • Radiology, Nuclear Medicine and Imaging 223
  • Molecular Biology 189
  • Oncology 120
  • Physiology 91
  • Neurology 81
Replace Kevin Brady with:
Kevin Brady United Kingdom
Viktoria Ruf Germany
Dewei Tang United States
Ann-Charlott Steffen Sweden
Sebastian Wetzel Germany
Alison Smigova United Kingdom
Benoît Hosten France
Sangeetha Bollini United States
Bin Yuan China
Ebrima Gibbs Canada
Sheila Ulufatu relative to Kevin Brady United Kingdom Kevin Brady's profile →
Citations per field
00.5×4.1×
Kevin Brady · 1×
Citations per year

Countries citing papers authored by Sheila Ulufatu

Since Specialization
Citations

This map shows the geographic impact of Sheila Ulufatu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Ulufatu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Ulufatu more than expected).

Fields of papers citing papers by Sheila Ulufatu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Ulufatu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Ulufatu. The network helps show where Sheila Ulufatu may publish in the future.

Co-authorship network of co-authors of Sheila Ulufatu

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Ulufatu. A scholar is included among the top collaborators of Sheila Ulufatu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Ulufatu. Sheila Ulufatu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 4
2 6
3 11
4 14
5 9
6 18
7 23
8 150
9 63
10 49
11 9
12 31
13 29
14 33
15 2

About Sheila Ulufatu

Sheila Ulufatu is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Neurology, having authored 15 papers that have together received 451 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), HER2/EGFR in Cancer Research (5 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Neurology (81 citations), Radiology, Nuclear Medicine and Imaging (223 citations) and Oncology (120 citations). Sheila Ulufatu has collaborated with scholars based in United States, Canada and France. Frequent co-authors include C. Andrew Boswell, Leslie A. Khawli, Eduardo E. Mundo, Nga Bien‐Ly, Yanmei Lu, Marcel van der Brug, Wilman Luk, Kwame Hoyte, Thomas G. Beach and Surinder Jeet. Their work appears in journals such as Journal of Biological Chemistry, Neuron and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026